Mesothelioma Press Releases by globenewswire

News Search | All News Topics > Mesothelioma News Topics: By Country | By State ; Press Releases by Industry Channel
Submit Your Press Release
Distribution channels: Healthcare & Pharmaceuticals Industry
00:05 GMT
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
Feb 27, 2025
Extendicare Announces 2024 Fourth Quarter and Full Year Results and Dividend Increase
Feb 27, 2025
TILT Sets Fourth Quarter and Full Year 2024 Conference Call for March 19 at 5:00 p.m. ET
Feb 27, 2025
RadNet Reports Fourth Quarter 2024 Results, Including Record Revenue and Adjusted EBITDA(1) and Releases 2025 Financial ...
Feb 27, 2025
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck ...
Feb 27, 2025
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
Feb 27, 2025
Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update
Feb 27, 2025
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
Feb 27, 2025
Pennant Reports Fourth Quarter and Fiscal Year 2024 Results
Feb 27, 2025
LeMaitre Q4 2024 Financial Results
Feb 27, 2025
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
Feb 27, 2025
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Feb 27, 2025
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results
Feb 27, 2025
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Feb 27, 2025
Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Feb 27, 2025
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
Feb 27, 2025
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Feb 27, 2025
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 27, 2025
Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
Feb 27, 2025
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
Feb 27, 2025
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2024
Feb 27, 2025
NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to ...
Feb 27, 2025
Kidney Month 2025: Bringing Kidney Disease into the Spotlight
Feb 27, 2025
Progyny, Inc. Announces Fourth Quarter 2024 Results
Feb 27, 2025
Standard BioTools to Participate in Upcoming Investor Conferences
Feb 27, 2025
Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Feb 27, 2025
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance
Feb 27, 2025
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
Feb 27, 2025
WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results
Feb 27, 2025
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Feb 27, 2025
Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
Feb 27, 2025
The International Myeloma Foundation Thanks Mr. Yelak Biru for His Dedicated Service to the Organization
Feb 27, 2025
Extendicare Announces Changes to Board of Directors
Feb 27, 2025
Microbix Hosts Ontario Premier Doug Ford & Team
Feb 27, 2025
MAPS Releases Template to Assist in Federal Drug Sentencing Reform Efforts
Feb 27, 2025
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
Feb 27, 2025
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive ...
Feb 27, 2025
Pharma Competitive Intelligence News Monitoring: A Case Study by DelveInsight
Feb 27, 2025
Global Nucleic Acid Amplification Testing Market to Grow Rapidly at an ~8% CAGR by 2032 | DelveInsight
Feb 27, 2025
WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight
Powered by EIN News